Berson & Corrado Investment Advisors Has Lowered Its Enzo Biochem (ENZ) Holding; ORKLA BORREGAARD AS (ORKLF) Sellers Decreased By 2.32% Their Shorts

Berson & Corrado Investment Advisors Llc decreased Enzo Biochem Inc (ENZ) stake by 26.79% reported in 2017Q3 SEC filing. Berson & Corrado Investment Advisors Llc sold 87,375 shares as Enzo Biochem Inc (ENZ)’s stock rose 31.87%. The Berson & Corrado Investment Advisors Llc holds 238,726 shares with $2.50 million value, down from 326,101 last quarter. Enzo Biochem Inc now has $394.65M valuation. The stock decreased 3.11% or $0.27 during the last trading session, reaching $8.41. About 103,170 shares traded. Enzo Biochem, Inc. (NYSE:ENZ) has risen 44.32% since December 27, 2016 and is uptrending. It has outperformed by 27.62% the S&P500.

ORKLA BORREGAARD AS (OTCMKTS:ORKLF) had a decrease of 2.32% in short interest. ORKLF’s SI was 636,900 shares in December as released by FINRA. Its down 2.32% from 652,000 shares previously. With 2,300 avg volume, 277 days are for ORKLA BORREGAARD AS (OTCMKTS:ORKLF)’s short sellers to cover ORKLF’s short positions. It closed at $10.35 lastly. It is down 0.00% since December 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Since October 25, 2017, it had 0 insider buys, and 3 insider sales for $1.51 million activity. Another trade for 22,866 shares valued at $235,062 was sold by O’Brien James Michael. RABBANI ELAZAR sold $730,526 worth of stock or 72,401 shares. WEINER BARRY W sold $547,214 worth of stock.

Analysts await Enzo Biochem, Inc. (NYSE:ENZ) to report earnings on March, 12. They expect $-0.01 earnings per share, up 50.00% or $0.01 from last year’s $-0.02 per share. After $-0.01 actual earnings per share reported by Enzo Biochem, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.